Mirabegron Tablets ER 25 Mg

Mirabegron Tablets ER 25 Mg is a prescription medication used for the treatment of overactive bladder (OAB) in adult patients. It helps reduce symptoms such as urinary urgency, increased frequency of urination, and urge urinary incontinence. Mirabegron is a beta-3 adrenergic agonist that works by relaxing the bladder muscle, allowing it to store urine more effectively and improving bladder control.

This extended-release formulation is designed for once-daily dosing, providing consistent therapeutic effect throughout the day under medical supervision.

What Is Mirabegron Tablets ER 25 Mg?

Mirabegron Tablets ER 25 Mg contains mirabegron, a selective beta-3 adrenergic receptor agonist. Unlike anticholinergic bladder medications, mirabegron works through a different mechanism and is often preferred for patients who cannot tolerate anticholinergic side effects such as dry mouth or constipation.

The 25 mg extended-release strength is commonly prescribed as a starting dose, with the option to adjust dosage based on patient response and tolerability.

How Mirabegron Tablets ER 25 Mg Works

Mirabegron improves bladder function by targeting receptors involved in bladder relaxation during the urine storage phase.

Mechanism of Action

• Activates beta-3 adrenergic receptors in the bladder

• Relaxes detrusor smooth muscle

• Increases bladder storage capacity

• Reduces urgency, frequency, and urge incontinence episodes

This targeted action helps improve quality of life in patients with overactive bladder symptoms.

Uses of Mirabegron Tablets ER 25 Mg

Mirabegron Tablets ER 25 Mg are prescribed for the management of overactive bladder symptoms.

Therapeutic Indications

• Treatment of overactive bladder (OAB)

• Reduction of urinary urgency

• Decrease in frequency of urination

• Management of urge urinary incontinence

Dosage and Administration

The dosage of Mirabegron Tablets ER 25 Mg should be determined by a qualified healthcare professional based on the patient’s medical condition and treatment response.

Administration Guidelines

• Taken orally once daily

• Swallow the tablet whole with water

• Can be taken with or without food

• Do not crush, chew, or split the tablet

• Do not discontinue treatment without consulting a healthcare provider

Dose adjustments may be made based on clinical response and tolerability.

Side Effects of Mirabegron Tablets ER 25 Mg

As with all medications, some patients may experience side effects while using Mirabegron extended-release tablets.

Common Side Effects

• Increased blood pressure

• Headache

• Nasopharyngitis (common cold symptoms)

• Urinary tract infection

• Constipation

Less Common Side Effects

• Palpitations

• Dizziness

• Abdominal discomfort

• Allergic reactions such as rash or itching

Patients should seek medical attention if they experience severe or persistent side effects.

Mirabegron Side Effects
Information on adverse reactions, safety considerations, and precautions related to mirabegron is available on WebMD.

Warnings and Precautions

Before starting Mirabegron Tablets ER 25 Mg, patients should inform their healthcare provider about any existing medical conditions.

Important Safety Information

• Not recommended for patients with severe uncontrolled hypertension

• Blood pressure should be monitored periodically during treatment

• Use with caution in patients with kidney or liver impairment

• Inform your doctor about all medications being taken to avoid drug interactions

• Use during pregnancy or breastfeeding only if clearly prescribed

Avoid self-medication and follow medical advice strictly.

Storage Instructions

• Store below 25°C

• Protect from moisture and direct sunlight

• Keep in original packaging until use

• Keep out of reach of children

  FAQ’s